gimli
WOCKPHARMA stock analysis context
WOCKHARDT Stock Context for AI Screening
WOCKHARDT LIMITED is a small-cap stock in Healthcare. This page summarizes key screening signals for WOCKHARDT, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about WOCKPHARMAPrice
₹1,575.40
1M return
+8.63%
3M return
+14.03%
Market cap
₹25,599.02 cr
PE
232.72
ROE
+2.64%
RSI
57.94
Turnover
₹79.62 cr
Why it can matter in screens
- Momentum: WOCKPHARMA is above 50DMA, above 200DMA; RSI is 57.94.
- Returns: 1M +8.63%, 3M +14.03%, 6M +20.14%.
- Liquidity: latest turnover is ₹79.62 cr.
- Valuation: PE 232.72, PB 4.85, ROE +2.64%, ROCE +5.21%.
- Growth: 3Y sales CAGR -3.16%, 3Y profit CAGR n/a.
Try these prompts
- Analyze WOCKHARDT with valuation, momentum and industry peers
- Compare WOCKPHARMA with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare WOCKPHARMA with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.